Results 81 to 90 of about 367,529 (264)

Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mosliciguat (BAY 1237592), the first soluble guanylate cyclase (sGC) activator in a dry powder inhaler (DPI), could potentially treat pulmonary hypertension with a more targeted delivery than systemic sGC stimulators. We report safety and tolerability of mosliciguat in healthy men.
Johannes Nagelschmitz   +7 more
wiley   +1 more source

Tic Cough in an Adolescent with Organic Brain Pathology—A Case Report and Literature Review

open access: yesBrain Sciences
Chronic cough in children and adolescents can be troublesome both to the patient and the whole family. The most common causes of chronic cough in children are protracted bacterial bronchitis and bronchial asthma.
Agnese Grinevica   +3 more
doaj   +1 more source

Cough, Cough-Induced, and Primary Cough Headache

open access: yesMatrix Science Medica, 2022
Jamir Pitton Rissardo   +1 more
openaire   +1 more source

Multifunctional Flexible Thermoelectric Fabric for Smart Wearables

open access: yesCarbon Energy, EarlyView.
This study designs a multifunctional rGO/PEDOT:PSS fabric integrating thermoelectric generation, signal sensing, and EMI shielding. It enables motion detection, respiratory monitoring, and fetal movement tracking. The fabric emphasizes flexibility, durability, comfort, and safety, making it suitable for wearable healthcare applications and advancing ...
Jia Wu   +10 more
wiley   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani   +11 more
wiley   +1 more source

New medical technologies in cough therapy: results of a double-blind randomized placebo-controlled multicenter clinical trial

open access: yesТерапевтический архив
Aim. To study the efficacy and safety of Eladis® in comparison with placebo in patients with non-productive cough. Materials and methods. A phase III clinical trial enrolled 250 patients aged 18–65 years with acute respiratory viral infection with ...
Ekaterina A. Polyakova   +4 more
doaj   +1 more source

A guide to neuromodulation in drug‐resistant epilepsy

open access: yesEpileptic Disorders, EarlyView.
Abstract Neuromodulation is approved for the treatment of drug‐resistant epilepsy. It has been increasingly utilized over the past two decades with the approval of deep brain stimulation (DBS) and responsive neurostimulation (RNS) in addition to vagus nerve stimulation (VNS)—particularly in patients who are not deemed to be good resective surgical ...
Prachi Parikh   +10 more
wiley   +1 more source

Application Practice of AI Empowering Post-discharge Specialized Disease Management in Postoperative Rehabilitation of the Lung Cancer Patients Undergoing Surgery

open access: yesChinese Journal of Lung Cancer
Background and objective Lung cancer is the leading malignancy in China in terms of both incidence and mortality. With increased health awareness and the widespread use of low-dose computed tomography (CT), early diagnosis rates have been steadily ...
Mei LI   +11 more
doaj   +1 more source

Combined course of severe whooping cough with rhinovirus infection and COVID-19 in an early child

open access: yesДетские инфекции (Москва)
Whooping cough does not lose its high importance in infectology. The combination of whooping cough with various viral infections can determine the nature of the disease and the development of complications. Of particular interest in modern conditions are
O. P. Popova   +5 more
doaj   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development

open access: yesEpilepsia, EarlyView.
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy